Evidence map›Paper›PMID 42295760›Full record

ArticleJAMA network open2026

Health Status Changes and Long-Term Clinical Outcomes in Patients With Atrial Fibrillation.

Takanori Ohata, Nobuhiro Ikemura, Shun Kohsaka, Paul S Chan, Ryo Nakamaru, Yasuyuki Shiraishi, Ikuko Ueda, Takehiro Kimura, Yoshinori Katsumata, Takahiko Nishiyama and 5 more

Abstract readMulticenter Study
In one paragraph

Article in JAMA network open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Takanori OhataDepartment of Cardiology, Keio University School of Medicine, Tokyo, Japan.
Nobuhiro IkemuraDepartment of Cardiology, Keio University School of Medicine, Tokyo, Japan.
Shun KohsakaDepartment of Cardiology, Keio University School of Medicine, Tokyo, Japan.
Paul S ChanSaint Luke's Mid America Heart Institute, Kansas City, Missouri.
Ryo NakamaruDepartment of Cardiovascular Medicine, Faculty of Medicine, Kyorin University, Tokyo, Japan.
Yasuyuki ShiraishiDepartment of Cardiology, Keio University School of Medicine, Tokyo, Japan.
Ikuko UedaDepartment of Cardiology, Keio University School of Medicine, Tokyo, Japan.
Takehiro KimuraDepartment of Cardiology, Keio University School of Medicine, Tokyo, Japan.
Yoshinori KatsumataDepartment of Cardiology, Keio University School of Medicine, Tokyo, Japan.
Takahiko NishiyamaDepartment of Cardiology, Keio University School of Medicine, Tokyo, Japan.
Iwao NakamuraDepartment of Cardiology, Hino Municipal Hospital, Hino, Japan.
Tomohiko OnoDepartment of Cardiology, National Hospital Organization Saitama Hospital, Wako, Japan.
Seiji TakatsukiDepartment of Cardiology, Keio University School of Medicine, Tokyo, Japan.
John A SpertusSaint Luke's Mid America Heart Institute, Kansas City, Missouri.
Masaki IedaDepartment of Cardiology, Keio University School of Medicine, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Improving health status, including symptoms and quality of life, is a key goal in the management of atrial fibrillation (AF). However, whether improvements in patient-reported health status are associated with subsequent clinical outcomes remains unclear. Objective: To evaluate the association between changes in health status and long-term adverse clinical outcomes in patients with AF. Design, Setting, and Participants: This cohort study used data from a prospective multicenter registry in Japan that enrolled patients aged 22 to 94 years with newly diagnosed AF or who were newly referred for AF management between September 20, 2012, and May 22, 2018. The registry collected follow-up data for up to 5 years. Eligible patients completed the Atrial Fibrillation Effect on Quality of Life patient-reported outcome measure (PROM) questionnaire at both baseline and 1-year follow-up. Clinical outcomes were assessed for 4 years following the 1-year AF PROM assessment. Data were analyzed between February 7 and July 14, 2025. Exposure: One-year change in the AF PROM overall summary score. Main Outcomes and Measures: The primary outcome was a composite of all-cause death, heart failure hospitalization, and stroke or transient ischemic attack over 4 years. Multivariable hierarchical regression models adjusted for baseline score, clinical factors, and comorbidities were used to evaluate associations between 1-year change in AF PROM overall summary score and outcomes. Results: Among 2744 patients (mean [SD] age, 67.8 [11.1] years; 1868 male [68.1%]; 1357 [49.6%] with paroxysmal AF), 1408 (51.3%) had improved health status (overall summary score increase of ≥5 points), 833 (30.4%) had stable health status, and 503 (18.3%) had worsened health status (overall summary score decrease of ≥5 points). During a mean (SD) follow-up of 3.1 (1.4) years after the 1-year assessment, the primary outcome occurred in 283 patients (10.3%). After adjustment for baseline characteristics (including baseline AF PROM score), improvement in the AF PROM overall summary score was associated with a lower risk of adverse outcomes (per 5-point increase: hazard ratio, 0.93 [95% CI, 0.89-0.96]; P < .001). Conclusions and Relevance: This cohort study of patients with AF in Japan found that greater improvements in 1-year AF PROM scores were associated with a lower risk of subsequent adverse clinical events. These findings support the prognostic value of PROMs and highlight the importance of monitoring health status in AF management.

Indexed as

Atrial FibrillationHealth StatusQuality of LifeAdultAgedAged, 80 and overFemaleHospitalizationHumansJapanMaleMiddle AgedPatient Reported Outcome MeasuresProspective StudiesRegistriesStroke

Identifiers

PMID42295760
PMCPMC13270273

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.